Anchorage Capital Group, L.L.C. Ginkgo Bioworks Holdings, Inc. Transaction History
Anchorage Capital Group, L.L.C.
- $378 Million
- Q1 2024
A detailed history of Anchorage Capital Group, L.L.C. transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Anchorage Capital Group, L.L.C. holds 69,854,593 shares of DNA stock, worth $37 Million. This represents 21.46% of its overall portfolio holdings.
Number of Shares
69,854,593
Previous 69,854,593
-0.0%
Holding current value
$37 Million
Previous $118 Million
31.36%
% of portfolio
21.46%
Previous 17.74%
Shares
3 transactions
Others Institutions Holding DNA
# of Institutions
360Shares Held
1.26BCall Options Held
845KPut Options Held
2.54M-
Baillie Gifford & CO233MShares$123 Million0.21% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl190MShares$100 Million1.57% of portfolio
-
Viking Global Investors LP143MShares$75.8 Million0.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA126MShares$66.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY72.9MShares$38.6 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $683M
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...